Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) on January 31 and set a price ...
Analyst Salveen Richter of Goldman Sachs maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), reducing the price target ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price hoisted by Scotiabank from $430.00 to $433.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price lifted by HC Wainwright from $535.00 to $550.00 in a research report sent to investors on Friday,Benzinga reports. HC Wainwright ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
Pleas note: we will be discontinuing the Global Markets Report after 28 February. Australian shares are set to open lower, ...
Chesley "Sully" Sullenberger, known for the heroic landing of US Airways Flight 1549 on the Hudson River, weighed in on the ...
Investing.com - Last weekend, a new name in the artificial intelligence arms race was becoming increasingly ubiquitous: ...
Following their investor field trip to Berlin ahead of Germany’s election next month, Morgan Stanley (NYSE:MS) strategists ...
President Donald Trump signed an executive order authorizing the tariffs Saturday, which will go into effect Tuesday, ...
AbbVie, Vertex Pharmaceuticals, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are stocks of companies that ...